RABI , F. et al. 2024. EFFECT OF DAPAGLIFLOZIN ON CARDIOVASCULAR OUTCOMES IN HFREF PATIENTS: IMPACT OF DIABETES MELLITUS TYPE 2 STATUS. Biological and Clinical Sciences Research Journal. 2024, 1 (May 2024), 830. DOI:https://doi.org/10.54112/bcsrj.v2024i1.830.